Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Proto Labs (PRLB) Financials

Proto Labs logo
$69.96 -1.18 (-1.65%)
As of 02:49 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Proto Labs

Annual Income Statements for Proto Labs

This table shows Proto Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 47 43 52 77 64 51 33 -103 17 17 21
Consolidated Net Income / (Loss)		 47 43 52 77 64 51 33 -103 17 17 21
Net Income / (Loss) Continuing Operations		 47 43 52 77 64 51 33 -103 17 17 21
Total Pre-Tax Income 		68 64 74 92 81 63 40 -98 28 25 31
Total Operating Income		 67 62 72 89 80 60 40 -98 28 20 25
Total Gross Profit		 154 167 194 239 235 218 223 215 222 223 237
Total Revenue		 264 298 344 446 459 434 488 488 504 501 533
Operating Revenue		 264 298 344 446 459 434 488 488 504 501 533
Total Cost of Revenue		 110 131 151 207 223 217 265 273 282 278 296
Operating Cost of Revenue		 110 131 151 207 223 217 265 273 282 278 296
Total Operating Expenses		 87 105 122 150 155 158 182 313 194 203 212
Selling, General & Admin Expense		 30 37 41 53 50 52 56 68 66 64 70
Marketing Expense		 39 46 57 69 73 69 82 83 88 92 98
Research & Development Expense		 18 22 24 29 33 37 44 38 40 41 43
Other Operating Expenses / (Income)		 - - - - - 0.00 0.00 - 0.22 5.59 0.34
Restructuring Charge		 - - - - - - - 6.92 0.00 0.00 0.75
Total Other Income / (Expense), net		 0.71 2.45 2.21 2.76 1.34 3.11 -0.16 0.11 -0.22 4.76 5.95
Other Income / (Expense), net		 0.71 2.45 2.21 2.76 1.34 3.11 -0.16 0.11 -0.22 4.76 5.95
Income Tax Expense		 21 22 23 15 18 12 6.81 5.59 11 8.08 9.82
Basic Earnings per Share		 $1.79 $1.62 $1.94 $2.84 $2.37 $1.90 $1.21 ($3.77) $0.66 $0.66 $0.89
Weighted Average Basic Shares Outstanding		 26.01M 26.37M 26.65M 26.98M 26.87M 26.74M 27.62M 27.41M 26.19M 25.10M 23.92M
Diluted Earnings per Share		 $1.77 $1.61 $1.93 $2.81 $2.35 $1.89 $1.21 ($3.77) $0.66 $0.66 $0.88
Weighted Average Diluted Shares Outstanding		 26.32M 26.56M 26.85M 27.28M 27.05M 26.90M 27.65M 27.41M 26.22M 25.21M 24.25M
Weighted Average Basic & Diluted Shares Outstanding		 26M 26.40M 26.70M 27M 26.79M 27.60M 27.47M 26.68M 25.72M 24.23M 23.78M

Quarterly Income Statements for Proto Labs

This table shows Proto Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 7.95 6.99 5.27 4.54 7.19 -0.40 3.60 4.43 7.22 6.00 8.11
Consolidated Net Income / (Loss)		 7.95 6.99 5.27 4.54 7.19 -0.40 3.60 4.43 7.22 6.00 8.11
Net Income / (Loss) Continuing Operations		 7.95 6.99 5.27 4.54 7.19 -0.40 3.60 4.43 7.22 6.00 8.11
Total Pre-Tax Income 		11 9.94 7.73 7.36 9.87 -0.28 5.99 6.67 10 8.15 11
Total Operating Income		 10 8.40 6.83 6.00 8.58 -1.50 4.53 4.97 8.81 6.80 9.84
Total Gross Profit		 59 56 57 57 57 52 56 60 61 60 64
Total Revenue		 131 125 128 126 126 122 126 135 135 136 139
Operating Revenue		 131 125 128 126 126 122 126 135 135 136 139
Total Cost of Revenue		 71 69 70 69 68 70 71 75 74 76 76
Operating Cost of Revenue		 71 69 70 69 68 70 71 75 74 76 76
Total Operating Expenses		 49 47 51 51 49 53 51 55 52 54 54
Selling, General & Admin Expense		 17 16 16 17 16 15 17 19 17 17 17
Marketing Expense		 22 22 23 23 23 23 24 25 25 25 25
Research & Development Expense		 10 9.49 11 11 9.77 9.70 11 11 11 10 11
Other Operating Expenses / (Income)		 0.02 - 0.00 0.00 0.00 - -0.04 0.15 0.04 0.19 0.00
Restructuring Charge		 - - - - - - 0.00 - - - 1.42
Total Other Income / (Expense), net		 0.32 1.54 0.90 1.36 1.29 1.21 1.45 1.71 1.44 1.35 1.48
Other Income / (Expense), net		 0.32 1.54 0.90 1.36 1.29 1.21 1.45 1.71 1.44 1.35 1.48
Income Tax Expense		 2.78 2.95 2.46 2.82 2.68 0.12 2.39 2.25 3.04 2.15 3.21
Basic Earnings per Share		 $0.31 $0.26 $0.21 $0.18 $0.29 ($0.02) $0.15 $0.19 $0.30 $0.25 $0.34
Weighted Average Basic Shares Outstanding		 26.02M 26.19M 25.62M 25.31M 24.98M 25.10M 24.14M 23.90M 23.89M 23.92M 23.84M
Diluted Earnings per Share		 $0.31 $0.26 $0.20 $0.18 $0.29 ($0.01) $0.15 $0.18 $0.30 $0.25 $0.33
Weighted Average Diluted Shares Outstanding		 26.03M 26.22M 25.78M 25.37M 25.02M 25.21M 24.44M 24.10M 24.19M 24.25M 24.29M
Weighted Average Basic & Diluted Shares Outstanding		 25.79M 25.72M 25.32M 25.15M 24.51M 24.23M 23.77M 23.87M 23.68M 23.78M 23.79M

Annual Cash Flow Statements for Proto Labs

This table details how cash moves in and out of Proto Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 4.32 21 -32 48 40 2.38 -62 -9.37 27 5.28 22
Net Cash From Operating Activities		 64 77 82 123 116 107 55 62 73 78 75
Net Cash From Continuing Operating Activities		 64 77 82 123 116 107 55 62 73 78 75
Net Income / (Loss) Continuing Operations		 47 43 52 77 64 51 33 -103 17 17 21
Consolidated Net Income / (Loss)		 47 43 52 77 64 51 33 -103 17 17 21
Depreciation Expense		 14 17 18 27 31 33 40 39 38 36 34
Non-Cash Adjustments To Reconcile Net Income		 5.74 5.69 8.92 9.64 11 15 19 137 20 20 16
Changes in Operating Assets and Liabilities, net		 -3.52 10 1.52 9.58 10 8.76 -38 -11 -1.93 5.82 3.26
Net Cash From Investing Activities		 -64 -61 -124 -63 -44 -95 -95 -43 -4.55 -14 -13
Net Cash From Continuing Investing Activities		 -64 -61 -124 -63 -44 -95 -95 -43 -4.55 -14 -13
Purchase of Property, Plant & Equipment		 -44 -34 -33 -87 -62 -47 -34 -22 -28 -9.17 -15
Purchase of Investments		 -66 -89 -29 -42 -50 -116 -16 -47 -1.00 -25 -17
Sale of Property, Plant & Equipment		 - - - - - 0.00 0.00 4.11 0.70 0.03 0.83
Sale and/or Maturity of Investments		 52 62 48 65 68 68 83 21 24 21 18
Net Cash From Financing Activities		 4.70 5.32 9.19 -10 -32 -11 -22 -28 -42 -59 -40
Net Cash From Continuing Financing Activities		 4.70 5.32 9.19 -10 -32 -11 -22 -28 -42 -59 -40
Repayment of Debt		 -0.15 0.00 0.00 -5.00 0.00 -0.15 -0.56 -0.53 -0.31 -0.30 -0.31
Repurchase of Common Equity		 0.00 0.00 -4.41 -12 -34 -15 -23 -30 -44 -60 -43
Issuance of Common Equity		 6.25 5.72 8.60 8.94 4.39 7.56 5.86 3.95 3.84 4.02 6.34
Other Financing Activities, net		 - - 0.00 -2.14 -2.49 -3.44 -4.23 -1.68 -1.44 -2.00 -3.43
Effect of Exchange Rate Changes		 -0.88 -0.92 0.95 - 0.05 - -0.05 -0.44 0.37 -0.42 1.03
Cash Interest Paid		 0.01 0.00 0.02 0.04 0.01 0.02 0.03 0.10 1.06 0.14 0.06
Cash Income Taxes Paid		 20 9.80 19 9.97 4.00 5.65 7.58 19 16 14 6.74

Quarterly Cash Flow Statements for Proto Labs

This table details how cash moves in and out of Proto Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 17 0.29 9.01 3.35 -8.28 1.20 -6.38 7.69 14 6.40 13
Net Cash From Operating Activities		 24 17 21 14 25 17 18 11 29 16 18
Net Cash From Continuing Operating Activities		 24 17 21 14 25 17 18 11 29 16 18
Net Income / (Loss) Continuing Operations		 7.95 6.99 5.27 4.54 7.19 -0.40 3.60 4.43 7.22 6.00 8.11
Consolidated Net Income / (Loss)		 7.95 6.99 5.27 4.54 7.19 -0.40 3.60 4.43 7.22 6.00 8.11
Depreciation Expense		 9.33 9.32 9.10 8.97 8.91 8.82 8.69 8.57 8.43 8.12 8.07
Non-Cash Adjustments To Reconcile Net Income		 4.66 4.37 4.26 4.25 4.46 6.63 4.22 4.49 3.70 3.79 3.08
Changes in Operating Assets and Liabilities, net		 2.23 -3.45 2.70 -3.32 4.20 2.24 1.87 -6.91 9.75 -1.45 -1.73
Net Cash From Investing Activities		 2.06 -14 4.42 -0.75 -14 -2.90 -2.91 -0.64 -4.25 -5.61 -4.77
Net Cash From Continuing Investing Activities		 2.06 -14 4.42 -0.75 -14 -2.90 -2.91 -0.64 -4.25 -5.61 -4.77
Purchase of Property, Plant & Equipment		 -3.11 -18 -2.59 -4.20 -1.56 -0.83 -1.26 -1.47 -4.06 -8.05 -3.54
Purchase of Investments		 - -1.00 0.00 - - -6.98 -6.55 -4.50 -2.50 -3.46 -9.01
Sale of Property, Plant & Equipment		 0.07 0.01 0.02 0.01 0.00 - 0.00 - 0.81 0.02 1.28
Sale and/or Maturity of Investments		 5.10 4.75 6.98 3.44 5.29 4.92 4.91 5.33 1.50 5.88 6.50
Net Cash From Financing Activities		 -9.07 -3.12 -17 -10 -19 -13 -22 -3.24 -11 -4.48 0.66
Net Cash From Continuing Financing Activities		 -9.07 -3.12 -17 -10 -19 -13 -22 -3.24 -11 -4.48 0.66
Repayment of Debt		 -0.07 -0.07 -0.07 -0.07 -0.07 -0.08 -0.08 -0.08 -0.08 -0.08 -0.08
Repurchase of Common Equity		 -8.99 -4.90 -16 -11 -19 -14 -21 -3.09 -13 -6.23 0.00
Issuance of Common Equity		 - - 0.00 - - - 0.29 1.79 2.11 2.15 3.61
Other Financing Activities, net		 -0.01 -1.99 -0.53 0.71 - -2.17 -1.25 -1.87 -0.00 -0.32 -2.87
Effect of Exchange Rate Changes		 -0.16 0.61 -0.12 -0.05 0.41 -0.65 0.08 0.99 -0.08 0.04 -0.28

Annual Balance Sheets for Proto Labs

This table presents Proto Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 361 414 519 619 674 744 929 802 772 744 763
Total Current Assets		 138 158 165 215 236 242 183 187 201 195 234
Cash & Equivalents		 48 69 37 85 125 128 66 57 84 89 111
Short-Term Investments		 33 39 57 47 35 34 12 24 19 14 17
Accounts Receivable		 36 34 52 59 57 58 80 76 73 67 79
Inventories, net		 9.77 9.31 11 10 10 11 13 14 14 12 14
Prepaid Expenses		 5.22 5.70 6.27 8.57 8.23 11 11 13 9.12 10 9.59
Current Deferred & Refundable Income Taxes		 6.03 0.45 1.83 5.76 0.00 0.54 1.32 4.04 2.23 2.91 2.47
Plant, Property, & Equipment, net		 125 139 166 228 264 283 280 258 254 227 215
Total Noncurrent Assets		 98 117 187 176 174 220 465 358 318 321 315
Long-Term Investments		 65 84 37 24 13 59 14 26 8.02 18 14
Noncurrent Note & Lease Receivables		 - - - 0.00 0.00 2.40 1.90 18 0.96 0.69 0.42
Goodwill		 29 29 129 129 129 129 401 274 274 274 274
Intangible Assets		 3.34 2.66 19 20 17 14 38 31 26 21 19
Other Noncurrent Operating Assets		 0.52 0.93 2.67 3.44 14 15 9.90 8.62 9.48 7.52 7.28
Total Liabilities & Shareholders' Equity		 361 414 519 619 674 744 929 802 772 744 763
Total Liabilities		 33 34 58 77 88 100 100 105 77 73 89
Total Current Liabilities		 26 23 44 53 48 50 55 72 50 53 67
Accounts Payable		 14 11 16 17 17 18 25 17 16 16 15
Accrued Expenses		 2.63 4.44 8.41 17 11 16 12 22 17 20 27
Current Employee Benefit Liabilities		 9.99 7.67 12 18 15 12 14 13 15 17 24
Other Current Liabilities		 - - - 0.00 3.34 3.82 3.85 19 1.88 1.60 1.44
Total Noncurrent Liabilities		 7.13 11 14 25 40 50 45 33 27 20 22
Noncurrent Deferred & Payable Income Tax Liabilities		 4.24 7.00 6.97 20 26 34 36 26 19 14 17
Other Noncurrent Operating Liabilities		 2.89 3.98 4.62 4.59 14 16 9.30 6.62 8.64 6.53 5.88
Total Equity & Noncontrolling Interests		 328 380 461 541 586 644 828 698 695 670 674
Total Preferred & Common Equity		 328 380 461 541 586 644 828 698 695 670 674
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 328 380 461 541 586 644 828 698 695 670 674
Common Stock		 199 214 242 259 268 285 469 474 467 454 454
Retained Earnings		 134 177 225 291 325 363 377 258 256 244 241
Accumulated Other Comprehensive Income / (Loss)		 -5.21 -11 -5.23 -8.49 -7.02 -3.42 -17 -34 -28 -28 -21

Quarterly Balance Sheets for Proto Labs

This table presents Proto Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 907 791 777 784 770 758 754 737 743 757 779
Total Current Assets		 192 189 185 205 210 208 193 194 206 226 249
Cash & Equivalents		 59 62 66 83 93 96 88 83 90 104 124
Short-Term Investments		 25 23 20 19 17 17 13 14 13 15 12
Accounts Receivable		 81 78 75 78 78 71 69 74 78 78 86
Inventories, net		 15 14 14 14 13 12 12 13 13 14 15
Prepaid Expenses		 12 11 8.50 8.72 9.43 10 10 9.59 9.99 10 11
Current Deferred & Refundable Income Taxes		 0.76 0.82 0.87 0.89 0.64 1.40 0.67 0.86 1.16 4.68 1.18
Plant, Property, & Equipment, net		 260 254 249 243 248 244 238 221 216 211 209
Total Noncurrent Assets		 455 349 343 337 312 307 323 322 322 320 321
Long-Term Investments		 29 20 16 12 3.26 0.00 17 19 20 19 22
Noncurrent Note & Lease Receivables		 1.52 17 17 17 0.89 0.83 0.76 0.63 0.56 0.49 0.36
Goodwill		 384 274 274 274 274 274 274 274 274 274 274
Intangible Assets		 32 30 28 27 24 23 23 21 21 20 18
Other Noncurrent Operating Assets		 8.48 8.09 7.82 7.08 9.04 8.63 8.01 7.02 6.88 6.57 6.93
Total Liabilities & Shareholders' Equity		 907 791 777 784 770 758 754 737 743 757 779
Total Liabilities		 96 108 95 99 82 73 74 81 79 92 95
Total Current Liabilities		 61 78 66 75 58 51 54 62 62 70 71
Accounts Payable		 17 20 16 18 15 16 15 16 16 17 20
Accrued Expenses		 25 23 19 21 21 18 18 24 26 28 33
Current Employee Benefit Liabilities		 15 15 12 16 16 16 18 19 19 23 17
Other Current Liabilities		 3.26 19 18 18 1.85 1.84 1.76 1.44 1.30 1.26 1.24
Total Noncurrent Liabilities		 35 30 28 25 24 22 20 19 16 22 25
Noncurrent Deferred & Payable Income Tax Liabilities		 27 23 21 17 16 15 13 12 9.74 16 19
Other Noncurrent Operating Liabilities		 8.51 6.60 7.51 7.56 7.58 7.44 7.35 6.50 6.64 6.36 5.77
Total Equity & Noncontrolling Interests		 811 683 683 685 687 685 680 657 665 665 683
Total Preferred & Common Equity		 811 683 683 685 687 685 680 657 665 665 683
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 811 683 683 685 687 685 680 657 665 665 683
Common Stock		 477 465 465 464 463 461 454 447 450 451 458
Retained Earnings		 381 251 247 251 253 253 253 237 239 239 249
Accumulated Other Comprehensive Income / (Loss)		 -47 -33 -29 -30 -29 -29 -27 -27 -25 -25 -23

Annual Metrics And Ratios for Proto Labs

This table displays calculated financial ratios and metrics derived from Proto Labs' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 26.02% 12.85% 15.58% 29.35% 2.95% -5.30% 12.36% 0.06% 3.17% -0.59% 6.44%
EBITDA Growth		 13.71% -0.41% 13.38% 26.40% -5.66% -14.74% -15.56% -172.46% 212.02% -7.64% 7.27%
EBIT Growth		 12.11% -5.36% 15.90% 23.13% -11.41% -22.47% -36.16% -343.57% 128.56% -11.73% 25.90%
NOPAT Growth		 10.55% -10.76% 22.32% 47.85% -15.72% -22.76% -30.71% -304.72% 125.30% -22.83% 28.23%
Net Income Growth		 11.72% -8.18% 21.24% 47.92% -16.89% -20.09% -34.39% -410.03% 116.64% -3.64% 28.01%
EPS Growth		 10.63% -9.04% 19.88% 45.60% -16.37% -19.57% -35.98% -411.57% 117.51% 0.00% 33.33%
Operating Cash Flow Growth		 12.04% 20.91% 5.48% 50.38% -5.59% -7.83% -48.36% 12.38% 18.03% 6.22% -4.27%
Free Cash Flow Firm Growth		 105.02% 2,548.70% -371.50% 123.75% 57.51% 1.79% -851.94% 127.50% -68.83% 102.55% -28.03%
Invested Capital Growth		 32.52% 2.79% 79.09% 15.24% 6.75% 2.70% 74.02% -19.76% -1.12% -6.02% -3.24%
Revenue Q/Q Growth		 7.18% -0.47% 6.76% 4.35% -0.19% -1.51% 3.91% -1.61% 1.91% -0.65% 2.84%
EBITDA Q/Q Growth		 3.38% -1.52% 4.99% 3.90% -1.11% -7.28% 3.78% -181.19% 207.29% -15.05% 13.53%
EBIT Q/Q Growth		 3.80% -3.35% 6.07% 2.61% -2.64% -11.00% 3.56% -408.20% 128.32% -29.29% 37.27%
NOPAT Q/Q Growth		 3.13% -5.17% 10.14% 5.95% -4.24% -11.47% 9.40% -387.71% 125.46% -34.64% 55.73%
Net Income Q/Q Growth		 4.03% -5.78% 10.45% 7.01% -6.05% -9.93% 7.51% -540.02% 116.43% -30.83% 43.15%
EPS Q/Q Growth		 4.12% -5.85% 9.66% 6.84% -6.00% -10.00% 8.04% -538.37% 117.41% -29.03% 41.94%
Operating Cash Flow Q/Q Growth		 9.58% -4.27% 4.33% 14.13% -4.68% -6.70% -2.78% -16.76% 10.09% 0.08% -1.12%
Free Cash Flow Firm Q/Q Growth		 -91.51% 191.18% -351.91% 121.96% 7.22% -3.39% 2.63% 9.79% -59.22% 72.65% -25.71%
Invested Capital Q/Q Growth		 10.82% -4.15% 65.86% 2.20% 0.75% -0.45% -0.89% -15.19% 2.54% -2.32% 0.98%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 58.46% 56.01% 56.27% 53.56% 51.29% 50.14% 45.62% 44.12% 44.06% 44.56% 44.48%
EBITDA Margin		 31.51% 27.81% 27.28% 26.66% 24.43% 21.99% 16.53% -11.97% 13.00% 12.07% 12.17%
Operating Margin		 25.43% 20.72% 20.97% 19.95% 17.41% 13.77% 8.27% -20.06% 5.59% 3.98% 4.71%
EBIT Margin		 25.69% 21.55% 21.61% 20.57% 17.70% 14.49% 8.23% -20.04% 5.55% 4.93% 5.83%
Profit (Net Income) Margin		 17.61% 14.33% 15.03% 17.19% 13.88% 11.71% 6.84% -21.18% 3.42% 3.31% 3.98%
Tax Burden Percent		 68.54% 66.50% 69.56% 83.56% 78.40% 80.81% 83.05% 105.71% 61.61% 67.25% 68.38%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 31.46% 33.50% 30.44% 16.44% 21.60% 19.19% 16.95% 0.00% 38.39% 32.75% 31.62%
Return on Invested Capital (ROIC)		 28.83% 22.26% 19.24% 20.60% 15.69% 11.58% 5.78% -10.33% 2.95% 2.36% 3.18%
ROIC Less NNEP Spread (ROIC-NNEP)		 28.47% 21.29% 18.28% 18.96% 15.05% 10.30% 5.86% 24.82% 3.07% -0.40% 0.09%
Return on Net Nonoperating Assets (RNNOA)		 -13.14% -10.18% -6.93% -5.32% -4.39% -3.31% -1.25% -3.23% -0.48% 0.07% -0.02%
Return on Equity (ROE)		 15.68% 12.07% 12.31% 15.28% 11.29% 8.27% 4.53% -13.56% 2.47% 2.43% 3.16%
Cash Return on Invested Capital (CROIC)		 0.85% 19.51% -37.43% 6.44% 9.16% 8.91% -48.25% 11.59% 4.08% 8.57% 6.47%
Operating Return on Assets (OROA)		 20.94% 16.57% 15.96% 16.11% 12.56% 8.88% 4.80% -11.31% 3.55% 3.26% 4.12%
Return on Assets (ROA)		 14.35% 11.02% 11.10% 13.46% 9.85% 7.18% 3.99% -11.96% 2.19% 2.19% 2.82%
Return on Common Equity (ROCE)		 15.68% 12.07% 12.31% 15.28% 11.29% 8.27% 4.53% -13.56% 2.47% 2.43% 3.16%
Return on Equity Simple (ROE_SIMPLE)		 14.20% 11.24% 11.23% 14.14% 10.87% 7.89% 4.03% -14.83% 2.48% 2.48% 0.00%
Net Operating Profit after Tax (NOPAT)		 46 41 50 74 63 48 34 -69 17 13 17
NOPAT Margin		 17.43% 13.78% 14.58% 16.67% 13.65% 11.13% 6.86% -14.04% 3.44% 2.67% 3.22%
Net Nonoperating Expense Percent (NNEP)		 0.36% 0.96% 0.96% 1.64% 0.64% 1.27% -0.08% -35.16% -0.12% 2.76% 3.09%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -9.83% 2.50% 2.00% 2.55%
Cost of Revenue to Revenue		 41.54% 43.99% 43.73% 46.44% 48.71% 49.86% 54.38% 55.88% 55.94% 55.44% 55.52%
SG&A Expenses to Revenue		 11.25% 12.30% 11.96% 11.78% 10.85% 11.91% 11.46% 13.83% 13.06% 12.84% 13.10%
R&D to Revenue		 6.95% 7.51% 6.84% 6.45% 7.13% 8.50% 9.06% 7.83% 7.97% 8.24% 8.03%
Operating Expenses to Revenue		 33.04% 35.29% 35.30% 33.61% 33.88% 36.37% 37.36% 64.18% 38.47% 40.59% 39.77%
Earnings before Interest and Taxes (EBIT)		 68 64 74 92 81 63 40 -98 28 25 31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 83 83 94 119 112 96 81 -58 65 60 65
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.09 3.57 5.95 5.64 4.64 6.37 1.71 0.99 1.44 1.43 1.78
Price to Tangible Book Value (P/TBV)		 5.64 3.90 8.75 7.77 6.18 8.19 3.63 1.76 2.54 2.56 3.14
Price to Revenue (P/Rev)		 6.31 4.55 7.97 6.85 5.92 9.45 2.90 1.42 1.99 1.91 2.25
Price to Earnings (P/E)		 35.82 31.78 53.01 39.87 42.69 80.68 42.45 0.00 58.34 57.74 56.40
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 2.79% 3.15% 1.89% 2.51% 2.34% 1.24% 2.36% 0.00% 1.71% 1.73% 1.77%
Enterprise Value to Invested Capital (EV/IC)		 8.36 6.22 7.81 7.51 6.17 9.17 1.80 0.99 1.53 1.52 1.99
Enterprise Value to Revenue (EV/Rev)		 5.76 3.91 7.60 6.50 5.55 8.94 2.71 1.20 1.77 1.67 1.98
Enterprise Value to EBITDA (EV/EBITDA)		 18.27 14.05 27.86 24.40 22.70 40.64 16.42 0.00 13.65 13.84 16.27
Enterprise Value to EBIT (EV/EBIT)		 22.41 18.13 35.18 31.62 31.33 61.69 32.97 0.00 31.98 33.93 33.98
Enterprise Value to NOPAT (EV/NOPAT)		 33.04 28.35 52.12 39.01 40.63 80.30 39.54 0.00 51.51 62.52 61.47
Enterprise Value to Operating Cash Flow (EV/OCF)		 23.73 15.03 32.03 23.57 21.92 36.30 23.98 9.44 12.20 10.76 14.17
Enterprise Value to Free Cash Flow (EV/FCFF)		 1,119.01 32.35 0.00 124.84 69.58 104.34 0.00 7.61 37.27 17.24 30.19
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.46 -0.48 -0.38 -0.28 -0.29 -0.32 -0.21 -0.13 -0.16 -0.17 -0.20
Leverage Ratio		 1.09 1.10 1.11 1.13 1.15 1.15 1.14 1.13 1.13 1.11 1.12
Compound Leverage Factor		 1.09 1.10 1.11 1.13 1.15 1.15 1.14 1.13 1.13 1.11 1.12
Debt to Total Capital		 0.00% 0.00% 1.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 1.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 98.93% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 -1.34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 -2.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 32.19 25.89 30.65 25.82 20.64 26.52 9.90 4.80 9.29 9.31 9.57
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.25 6.74 3.77 4.08 4.97 4.82 3.34 2.61 4.04 3.66 3.49
Quick Ratio		 4.45 6.08 3.33 3.62 4.58 4.37 2.87 2.18 3.54 3.18 3.09
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 1.36 36 -98 23 37 37 -280 77 24 49 35
Operating Cash Flow to CapEx		 144.48% 230.54% 250.49% 141.13% 186.49% 227.55% 161.48% 353.16% 267.26% 851.99% 531.87%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.82 0.77 0.74 0.78 0.71 0.61 0.58 0.56 0.64 0.66 0.71
Accounts Receivable Turnover		 8.75 8.49 8.05 8.05 7.87 7.53 7.08 6.25 6.76 7.19 7.33
Inventory Turnover		 13.74 13.74 14.64 19.38 22.16 20.69 22.10 20.41 20.70 21.39 22.17
Fixed Asset Turnover		 2.43 2.25 2.25 2.26 1.87 1.59 1.73 1.82 1.97 2.08 2.41
Accounts Payable Turnover		 10.19 10.50 11.08 12.43 13.06 12.36 12.17 12.78 17.09 17.83 19.34
Days Sales Outstanding (DSO)		 41.70 42.97 45.33 45.32 46.39 48.45 51.57 58.40 53.99 50.77 49.80
Days Inventory Outstanding (DIO)		 26.56 26.56 24.93 18.84 16.47 17.64 16.52 17.88 17.63 17.06 16.47
Days Payable Outstanding (DPO)		 35.81 34.75 32.95 29.36 27.95 29.54 29.99 28.57 21.36 20.47 18.87
Cash Conversion Cycle (CCC)		 32.45 34.78 37.31 34.80 34.91 36.56 38.10 47.71 50.27 47.37 47.39
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 182 187 335 386 412 423 737 591 584 549 532
Invested Capital Turnover		 1.65 1.62 1.32 1.24 1.15 1.04 0.84 0.74 0.86 0.88 0.99
Increase / (Decrease) in Invested Capital		 45 5.08 148 51 26 11 313 -146 -6.63 -35 -18
Enterprise Value (EV)		 1,521 1,165 2,618 2,898 2,544 3,883 1,325 586 894 837 1,055
Market Capitalization		 1,666 1,357 2,745 3,053 2,717 4,104 1,417 692 1,005 958 1,198
Book Value per Share		 $12.52 $14.37 $17.31 $20.00 $21.89 $24.08 $30.03 $25.73 $26.96 $27.34 $28.46
Tangible Book Value per Share		 $11.29 $13.18 $11.77 $14.51 $16.43 $18.74 $14.13 $14.47 $15.35 $15.29 $16.10
Total Capital		 328 380 466 541 586 644 828 698 695 670 674
Total Debt		 0.00 0.00 5.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -146 -193 -126 -155 -174 -221 -92 -107 -111 -121 -142
Capital Expenditures (CapEx)		 44 34 33 87 62 47 34 18 27 9.14 14
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 31 26 32 31 28 30 51 35 48 38 38
Debt-free Net Working Capital (DFNWC)		 112 134 126 163 189 192 129 115 151 142 167
Net Working Capital (NWC)		 112 134 121 163 189 192 129 115 151 142 167
Net Nonoperating Expense (NNE)		 -0.49 -1.63 -1.54 -2.30 -1.05 -2.51 0.13 35 0.13 -3.20 -4.07
Net Nonoperating Obligations (NNO)		 -146 -193 -126 -155 -174 -221 -92 -107 -111 -121 -142
Total Depreciation and Amortization (D&A)		 15 19 20 27 31 33 40 39 38 36 34
Debt-free, Cash-free Net Working Capital to Revenue		 11.69% 8.75% 9.32% 6.92% 6.14% 6.92% 10.47% 7.14% 9.56% 7.68% 7.21%
Debt-free Net Working Capital to Revenue		 42.31% 45.08% 36.65% 36.50% 41.17% 44.14% 26.35% 23.54% 29.96% 28.27% 31.24%
Net Working Capital to Revenue		 42.31% 45.08% 35.20% 36.50% 41.17% 44.14% 26.35% 23.54% 29.96% 28.27% 31.24%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.79 $1.62 $1.94 $2.84 $2.37 $1.90 $1.21 ($3.77) $0.66 $0.66 $0.89
Adjusted Weighted Average Basic Shares Outstanding		 26.01M 26.37M 26.65M 26.98M 26.87M 26.74M 27.62M 27.41M 26.19M 25.10M 23.92M
Adjusted Diluted Earnings per Share		 $1.77 $1.61 $1.93 $2.81 $2.35 $1.89 $1.21 ($3.77) $0.66 $0.66 $0.88
Adjusted Weighted Average Diluted Shares Outstanding		 26.32M 26.56M 26.85M 27.28M 27.05M 26.90M 27.65M 27.41M 26.22M 25.21M 24.25M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 26.20M 26.53M 26.90M 26.98M 26.79M 27.60M 27.47M 26.68M 25.72M 24.23M 23.78M
Normalized Net Operating Profit after Tax (NOPAT)		 46 41 50 74 63 48 34 19 17 17 18
Normalized NOPAT Margin		 17.43% 13.78% 14.58% 16.67% 13.65% 11.13% 6.86% 3.86% 3.47% 3.42% 3.32%
Pre Tax Income Margin		 25.69% 21.55% 21.61% 20.57% 17.70% 14.49% 8.23% -20.04% 5.55% 4.93% 5.83%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 3.01% 0.94% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 3.01% 0.94% 8.52% 15.97% 52.66% 28.87% 69.76% -28.67% 255.23% 363.27% 202.26%

Quarterly Metrics And Ratios for Proto Labs

This table displays calculated financial ratios and metrics derived from Proto Labs' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 23,775,160.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 23,775,160.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.34
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 7.38% 8.17% 1.61% 2.75% -3.89% -2.64% -1.32% 7.51% 7.76% 12.11% 10.40%
EBITDA Growth		 27.47% 117.95% 16.65% 39.17% -6.42% -55.63% -12.78% -6.66% -0.52% 90.51% 32.09%
EBIT Growth		 77.91% 108.52% 53.32% 228.57% -8.08% -102.84% -22.53% -9.32% 3.88% 2,990.78% 89.09%
NOPAT Growth		 94.54% 107.20% 135.31% 485.92% -19.00% -117.72% -41.47% -10.93% -0.78% 578.17% 158.81%
Net Income Growth		 101.32% 106.07% 98.12% 1,285.38% -9.62% -105.78% -31.68% -2.49% 0.38% 1,584.90% 125.37%
EPS Growth		 121.43% 106.21% 100.00% 1,900.00% -6.45% -103.85% -25.00% 0.00% 3.45% 2,600.00% 120.00%
Operating Cash Flow Growth		 17.81% 63.84% -5.49% 55.49% 2.38% 0.38% -13.87% -26.72% 17.52% -4.87% -4.59%
Free Cash Flow Firm Growth		 168.20% -80.28% -94.14% -91.28% -89.68% 172.35% 320.72% 201.61% 203.86% -33.24% -38.59%
Invested Capital Growth		 -18.22% -1.12% -0.70% -1.31% -1.34% -6.02% -5.89% -5.38% -6.41% -3.24% -2.85%
Revenue Q/Q Growth		 6.90% -4.33% 2.27% -1.77% -0.01% -3.08% 3.66% 7.02% 0.22% 0.83% 2.08%
EBITDA Q/Q Growth		 70.98% -4.05% -12.59% -2.95% 14.97% -54.51% 71.85% 3.85% 22.54% -12.89% 19.15%
EBIT Q/Q Growth		 379.24% -7.42% -22.26% -4.74% 34.08% -102.86% 2,222.34% 11.51% 53.60% -20.48% 38.82%
NOPAT Q/Q Growth		 904.79% -23.48% -21.16% -20.51% 68.92% -116.74% 360.36% 20.97% 88.15% -19.31% 40.92%
Net Income Q/Q Growth		 2,176.76% -12.12% -24.64% -13.82% 58.35% -105.62% 990.84% 23.01% 63.00% -16.87% 35.21%
EPS Q/Q Growth		 3,200.00% -16.13% -23.08% -10.00% 61.11% -103.45% 1,600.00% 20.00% 66.67% -16.67% 32.00%
Operating Cash Flow Q/Q Growth		 160.30% -28.75% 23.86% -32.31% 71.39% -30.14% 6.27% -42.41% 174.85% -43.45% 6.60%
Free Cash Flow Firm Q/Q Growth		 3.82% -90.69% -30.66% 30.10% 22.91% 145.62% 7.12% -6.73% 23.82% -46.03% -1.47%
Invested Capital Q/Q Growth		 -1.71% 2.54% -1.73% -0.36% -1.74% -2.32% -1.59% 0.18% -2.80% 0.98% -1.20%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 45.36% 44.63% 44.93% 45.01% 45.56% 42.68% 44.13% 44.26% 45.28% 44.23% 45.64%
EBITDA Margin		 15.35% 15.40% 13.16% 13.00% 14.95% 7.02% 11.63% 11.29% 13.80% 11.92% 13.92%
Operating Margin		 7.97% 6.71% 5.34% 4.78% 6.83% -1.23% 3.59% 3.68% 6.51% 4.98% 7.06%
EBIT Margin		 8.21% 7.95% 6.04% 5.86% 7.86% -0.23% 4.74% 4.94% 7.57% 5.97% 8.12%
Profit (Net Income) Margin		 6.09% 5.59% 4.12% 3.61% 5.72% -0.33% 2.85% 3.28% 5.33% 4.40% 5.82%
Tax Burden Percent		 74.09% 70.34% 68.19% 61.68% 72.85% 143.26% 60.13% 66.33% 70.39% 73.59% 71.67%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 25.91% 29.66% 31.81% 38.32% 27.15% 0.00% 39.87% 33.67% 29.61% 26.41% 28.33%
Return on Invested Capital (ROIC)		 4.61% 4.05% 3.19% 2.60% 4.43% -0.76% 1.93% 2.23% 4.36% 3.62% 5.19%
ROIC Less NNEP Spread (ROIC-NNEP)		 4.40% 3.05% 2.63% 1.83% 3.62% -1.31% 1.17% 1.27% 3.57% 2.86% 4.42%
Return on Net Nonoperating Assets (RNNOA)		 -0.67% -0.48% -0.42% -0.29% -0.62% 0.22% -0.20% -0.22% -0.68% -0.56% -0.90%
Return on Equity (ROE)		 3.94% 3.57% 2.78% 2.32% 3.81% -0.54% 1.73% 2.01% 3.68% 3.06% 4.28%
Cash Return on Invested Capital (CROIC)		 9.28% 4.08% 4.21% 5.12% 4.97% 8.57% 8.13% 7.52% 8.64% 6.47% 6.93%
Operating Return on Assets (OROA)		 4.80% 5.09% 3.92% 3.89% 5.15% -0.15% 3.14% 3.35% 5.20% 4.23% 5.85%
Return on Assets (ROA)		 3.56% 3.58% 2.67% 2.40% 3.75% -0.22% 1.89% 2.22% 3.66% 3.11% 4.20%
Return on Common Equity (ROCE)		 3.94% 3.57% 2.78% 2.32% 3.81% -0.54% 1.73% 2.01% 3.68% 3.06% 4.28%
Return on Equity Simple (ROE_SIMPLE)		 -15.31% 0.00% 2.89% 3.61% 3.53% 0.00% 2.27% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 7.72 5.90 4.66 3.70 6.25 -1.05 2.72 3.30 6.20 5.00 7.05
NOPAT Margin		 5.90% 4.72% 3.64% 2.95% 4.98% -0.86% 2.16% 2.44% 4.58% 3.67% 5.06%
Net Nonoperating Expense Percent (NNEP)		 0.21% 1.00% 0.56% 0.78% 0.81% 0.55% 0.76% 0.96% 0.79% 0.76% 0.77%
Return On Investment Capital (ROIC_SIMPLE)		 - 0.85% - - - -0.16% 0.41% 0.50% 0.93% 0.74% 1.03%
Cost of Revenue to Revenue		 54.64% 55.37% 55.07% 54.99% 54.44% 57.32% 55.87% 55.74% 54.72% 55.77% 54.36%
SG&A Expenses to Revenue		 13.05% 12.86% 12.76% 13.21% 12.94% 12.46% 13.35% 13.88% 12.68% 12.49% 12.21%
R&D to Revenue		 7.73% 7.59% 8.73% 8.49% 7.78% 7.97% 8.41% 8.27% 7.91% 7.56% 7.56%
Operating Expenses to Revenue		 37.39% 37.92% 39.60% 40.23% 38.73% 43.90% 40.54% 40.58% 38.77% 39.25% 38.58%
Earnings before Interest and Taxes (EBIT)		 11 9.94 7.73 7.36 9.87 -0.28 5.99 6.67 10 8.15 11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 20 19 17 16 19 8.54 15 15 19 16 19
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.01 1.44 1.34 1.14 1.09 1.43 1.29 1.43 1.80 1.78 1.98
Price to Tangible Book Value (P/TBV)		 1.79 2.54 2.37 2.02 1.93 2.56 2.35 2.57 3.22 3.14 3.46
Price to Revenue (P/Rev)		 1.39 1.99 1.82 1.54 1.46 1.91 1.70 1.87 2.30 2.25 2.48
Price to Earnings (P/E)		 0.00 58.34 46.49 31.59 30.79 57.74 56.90 64.26 80.50 56.40 52.64
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 1.71% 2.15% 3.17% 3.25% 1.73% 1.76% 1.56% 1.24% 1.77% 1.90%
Enterprise Value to Invested Capital (EV/IC)		 1.01 1.53 1.41 1.17 1.10 1.52 1.36 1.53 2.01 1.99 2.28
Enterprise Value to Revenue (EV/Rev)		 1.16 1.77 1.60 1.31 1.23 1.67 1.47 1.63 2.04 1.98 2.19
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 13.65 11.92 9.23 8.72 13.84 12.56 14.47 18.48 16.27 17.21
Enterprise Value to EBIT (EV/EBIT)		 0.00 31.98 26.40 18.71 17.80 33.93 31.96 37.25 46.67 33.98 32.91
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 51.51 40.00 30.55 30.31 62.52 63.93 75.03 95.78 61.47 55.64
Enterprise Value to Operating Cash Flow (EV/OCF)		 8.62 12.20 11.23 8.67 7.99 10.76 9.79 11.67 14.02 14.17 16.26
Enterprise Value to Free Cash Flow (EV/FCFF)		 9.76 37.27 33.35 22.68 22.07 17.24 16.18 19.80 22.44 30.19 32.43
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.15 -0.16 -0.16 -0.16 -0.17 -0.17 -0.17 -0.17 -0.19 -0.20 -0.20
Leverage Ratio		 1.13 1.13 1.14 1.12 1.13 1.11 1.12 1.11 1.12 1.12 1.13
Compound Leverage Factor		 1.13 1.13 1.14 1.12 1.13 1.11 1.12 1.11 1.12 1.12 1.13
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 5.48 9.22 8.09 7.85 7.41 9.20 7.69 8.67 9.20 9.47 9.99
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.74 4.04 3.60 4.08 3.59 3.66 3.13 3.31 3.24 3.49 3.51
Quick Ratio		 2.43 3.54 3.21 3.61 3.16 3.18 2.75 2.91 2.83 3.09 3.14
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 135 13 8.69 11 14 34 37 34 42 23 22
Operating Cash Flow to CapEx		 796.41% 94.79% 831.89% 344.78% 1,596.00% 2,083.61% 1,456.34% 720.98% 894.80% 204.95% 775.59%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.58 0.64 0.65 0.66 0.66 0.66 0.66 0.68 0.69 0.71 0.72
Accounts Receivable Turnover		 6.22 6.76 6.51 6.98 6.82 7.19 6.58 6.83 7.04 7.33 6.85
Inventory Turnover		 19.68 20.70 20.68 21.01 21.14 21.39 21.35 22.25 21.87 22.17 21.46
Fixed Asset Turnover		 1.97 1.97 2.02 2.07 2.10 2.08 2.13 2.21 2.31 2.41 2.54
Accounts Payable Turnover		 16.06 17.09 15.96 17.30 16.83 17.83 17.61 18.03 17.88 19.34 16.78
Days Sales Outstanding (DSO)		 58.69 53.99 56.08 52.29 53.52 50.77 55.48 53.43 51.84 49.80 53.27
Days Inventory Outstanding (DIO)		 18.55 17.63 17.65 17.37 17.27 17.06 17.10 16.40 16.69 16.47 17.01
Days Payable Outstanding (DPO)		 22.72 21.36 22.87 21.09 21.68 20.47 20.72 20.24 20.41 18.87 21.76
Cash Conversion Cycle (CCC)		 54.52 50.27 50.86 48.57 49.10 47.37 51.85 49.59 48.12 47.39 48.52
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 570 584 574 572 562 549 541 541 526 532 525
Invested Capital Turnover		 0.78 0.86 0.88 0.88 0.89 0.88 0.90 0.91 0.95 0.99 1.03
Increase / (Decrease) in Invested Capital		 -127 -6.63 -4.04 -7.61 -7.65 -35 -34 -31 -36 -18 -15
Enterprise Value (EV)		 574 894 809 669 621 837 733 829 1,056 1,055 1,198
Market Capitalization		 689 1,005 922 782 739 958 849 952 1,194 1,198 1,356
Book Value per Share		 $26.25 $26.96 $26.82 $27.07 $27.04 $27.34 $27.10 $27.96 $27.84 $28.46 $28.73
Tangible Book Value per Share		 $14.73 $15.35 $15.18 $15.32 $15.23 $15.29 $14.94 $15.57 $15.55 $16.10 $16.47
Total Capital		 685 695 687 685 680 670 657 665 665 674 683
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -115 -111 -113 -113 -118 -121 -116 -123 -138 -142 -158
Capital Expenditures (CapEx)		 3.04 18 2.57 4.19 1.55 0.83 1.26 1.47 3.25 8.03 2.26
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 27 48 42 44 39 38 35 40 37 38 42
Debt-free Net Working Capital (DFNWC)		 130 151 152 157 139 142 132 143 156 167 178
Net Working Capital (NWC)		 130 151 152 157 139 142 132 143 156 167 178
Net Nonoperating Expense (NNE)		 -0.24 -1.09 -0.61 -0.84 -0.94 -0.64 -0.87 -1.13 -1.01 -0.99 -1.06
Net Nonoperating Obligations (NNO)		 -115 -111 -113 -113 -118 -121 -116 -123 -138 -142 -158
Total Depreciation and Amortization (D&A)		 9.33 9.32 9.10 8.97 8.91 8.82 8.69 8.57 8.43 8.12 8.07
Debt-free, Cash-free Net Working Capital to Revenue		 5.50% 9.56% 8.36% 8.59% 7.70% 7.68% 7.11% 7.89% 7.10% 7.21% 7.61%
Debt-free Net Working Capital to Revenue		 26.27% 29.96% 30.04% 30.76% 27.63% 28.27% 26.51% 28.18% 30.10% 31.24% 32.56%
Net Working Capital to Revenue		 26.27% 29.96% 30.04% 30.76% 27.63% 28.27% 26.51% 28.18% 30.10% 31.24% 32.56%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.31 $0.26 $0.21 $0.18 $0.29 ($0.02) $0.15 $0.19 $0.30 $0.25 $0.34
Adjusted Weighted Average Basic Shares Outstanding		 26.02M 26.19M 25.62M 25.31M 24.98M 25.10M 24.14M 23.90M 23.89M 23.92M 23.84M
Adjusted Diluted Earnings per Share		 $0.31 $0.26 $0.20 $0.18 $0.29 ($0.01) $0.15 $0.18 $0.30 $0.25 $0.33
Adjusted Weighted Average Diluted Shares Outstanding		 26.03M 26.22M 25.78M 25.37M 25.02M 25.21M 24.44M 24.10M 24.19M 24.25M 24.29M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 25.79M 25.72M 25.32M 25.15M 24.51M 24.23M 23.77M 23.87M 23.68M 23.78M 23.79M
Normalized Net Operating Profit after Tax (NOPAT)		 7.72 5.90 4.66 3.70 6.25 -1.05 2.72 3.30 6.20 5.00 8.07
Normalized NOPAT Margin		 5.90% 4.72% 3.64% 2.95% 4.98% -0.86% 2.16% 2.44% 4.58% 3.67% 5.79%
Pre Tax Income Margin		 8.21% 7.95% 6.04% 5.86% 7.86% -0.23% 4.74% 4.94% 7.57% 5.97% 8.12%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -53.07% 255.23% 195.90% 164.94% 212.01% 363.27% 436.58% 387.00% 344.06% 202.26% 85.71%

Financials Breakdown Chart

Key Financial Trends

Proto Labs Inc (PRLB) has shown a generally constructive trajectory in its latest four quarterly reports. Below are the top trends drawn from the income statements, cash flow statements, and balance sheets for 2022–2025 (latest quarters provided), focused on items that may matter for retail investors.

  • Revenue growth in the latest quarter: Q4 2025 operating revenue reached $136.49M, up from $121.75M in Q4 2024, signaling continued demand and scale expansion.
  • Stable, healthy gross margins: Q4 2025 gross profit $60.37M on $136.49M revenue (about 44% margin), with margin staying in the mid-40s across 2025.
  • Net income turned positive in late-2025: Net income attributable to common shareholders for Q4 2025 was $5.999M with basic/diluted EPS of $0.25, marking a return to profitability after recent quarterly fluctuations.
  • Robust operating cash flow: Net cash from continuing operating activities was $16.45M in Q4 2025, and as high as $29.09M in Q3 2025, indicating strong cash generation from core operations.
  • Strong liquidity position: Cash & equivalents stood at about $104.4M in 2025 Q3–Q4, reflecting improved liquidity to fund operations and investments.
  • Earnings per share trend improves: Q4 2025 shows Basic EPS of $0.25 and Diluted EPS of $0.25, aligning with improving profitability and shareholder returns.
  • Capex remains modest and variable: Quarterly purchases of property, plant & equipment ranged roughly from $1.3M to $8.1M in 2025 (e.g., Q4 2025 capex about $8.05M), indicating capex is a manageable cash outflow rather than a headwind.
  • Financing activity outflows persist, but are part of capital actions: Net cash from financing activities has been negative in multiple quarters (e.g., Q4 2025: −$4.48M, Q3 2025: −$10.72M, Q2 2025: −$3.24M, Q1 2025: −$21.93M), driven by stock repurchases and debt actions rather than ongoing operating needs.
  • Financing outflows weigh on cash pressure: Ongoing negative financing cash flow reduces cash balance headroom and could be a drag if operating cash flow slows.
  • Large goodwill and intangible asset base as a potential impairment risk: Goodwill (~$274M) and substantial intangible assets (~$20–40M, varying by quarter) contribute to a higher asset base that could face impairment if market conditions deteriorate.
05/21/26 02:49 PM ETAI Generated. May Contain Errors.

Proto Labs Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Proto Labs' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Proto Labs' net income appears to be on a downward trend, with a most recent value of $21.24 million in 2025, falling from $46.51 million in 2015. The previous period was $16.59 million in 2024. Check out Proto Labs' forecast to explore projected trends and price targets.

Proto Labs' total operating income in 2025 was $25.11 million, based on the following breakdown:
  • Total Gross Profit: $237.14 million
  • Total Operating Expenses: $212.03 million

Over the last 10 years, Proto Labs' total revenue changed from $264.11 million in 2015 to $533.13 million in 2025, a change of 101.9%.

Proto Labs' total liabilities were at $89.48 million at the end of 2025, a 22.0% increase from 2024, and a 168.0% increase since 2015.

In the past 10 years, Proto Labs' cash and equivalents has ranged from $36.71 million in 2017 to $127.60 million in 2020, and is currently $110.83 million as of their latest financial filing in 2025.

Over the last 10 years, Proto Labs' book value per share changed from 12.52 in 2015 to 28.46 in 2025, a change of 127.3%.


Related Companies

Financial statements for NYSE:PRLB last updated on 5/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel